News and features

Researchers have gained new understandings of two key complexes of cancer-related proteins by producing the most detailed ever maps of the structures they form when they come together.

Testicular cancer can be prevented from coming back using half the amount of chemotherapy that is currently used, a new clinical trial has shown.

A new study has uncovered a previously unknown role for the enzyme EXD2, identifying it as a potential drug target for cancer therapy.

The first patient has been treated, as part of a clinical trial, with an innovative new technology called Acoustic Cluster Therapy that uses microscopic clusters of bubbles and liquid droplets to enhance the delivery of chemotherapy drugs to tumours. The new therapy could improve targeting of chemotherapy and reduce doses.

A blood test can help identify rare mutations in advanced breast cancer, which may enable patients to access effective treatment more quickly in the future, a new clinical trial has found.

Professor Paul Workman has announced his intention to step down as Chief Executive of The Institute of Cancer Research, London, in around a year's time after more than six years in the role.

The strong public focus on a ‘cure for cancer’ is masking dramatic progress in extending the lives of patients with advanced cancer and turning it into a manageable disease long term, a YouGov poll of members of the public and cancer patients has found.

We've selected a range of discoveries from 2018/19 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.

A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted therapy for more than a year.

People in the UK will for the first time have their entire genetic code read from samples taken at a GP practice as part of a pioneering study to assess the potential benefits of screening for gene faults that increase the risk of disease.

Familiar faces and voices from stage and screen came together on Tuesday 3 December to celebrate the start of the Christmas season at the 17th annual Carols from Chelsea service in support of The Institute of Cancer Research, London.

A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows.